Vascular Endothelial Growth Factor
Navigation Links
Vascular Endothelial Growth Factor
| Products | Vascular Endothelial Growth Factor |
| Company | ARUP Laboratories |
| Item | Vascular Endothelial Growth Factor |
| Features | |
| Description | ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics. |
| Info | ARUP Laboratories Customer Service: (800) 522-2787 Web site: http://www.aruplab.com |
Related medicine products :
1. Vascular Clamps B-1
2. Vascular Clamps B-2
3. Vascular Clamps B-3
4. Vascular Clamps HD-S
5. Vascular Clamps RD-S
6. Vascular Clamps ABB-11
7. Vasoguard Vascular Doppler
8. VersaLab Vascular Doppler
9. Vasoguard Microlite Vascular Doppler
10. PINNACLE Introducer Sheath Designed for Vascular Access
11. CVS4 Complete Vascular System
Breaking Medicine News(10 mins):Health News:REES Announces New Baltimore Office 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11
[0] REES Announces New Baltimore Office [0] Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative[0] Wellness Manufacturer Wins Two 2009 American Spa Awards [1] Obesity and Inactivity -- The Biggest Threat to the Nation's Health[1] Winner Medical Reports Fourth Quarter and Fiscal 2009 Results
Other Medicine News:Health News:Resilin Protein from Flea can be used for cardiovascular disease 2Health News:Osteopontin: a useful biomarker in asbestos-related cancer 2Health News:Dermaseptins: Potent vaginal contraceptives 2Health News:Incorrect lifestyle may be the cause of male infertility 2
Resilin Protein from Flea can be used for cardiovascular diseaseOsteopontin: a useful biomarker in asbestos-related cancerDigestive acid production dependent on newly found hormone Dermaseptins: Potent vaginal contraceptives Vical Biotech and NIH jointly develops HIV vaccineIncorrect lifestyle may be the cause of male infertility
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 1Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 2The Japanese Cancer Association and Debiopharm Group Present the JCA Mauvernay Award to Dr Ushijima for his Oncology Research 5204 1The Japanese Cancer Association and Debiopharm Group Present the JCA Mauvernay Award to Dr Ushijima for his Oncology Research 5204 2The Japanese Cancer Association and Debiopharm Group Present the JCA Mauvernay Award to Dr Ushijima for his Oncology Research 5204 3Abidance Consulting Partners with the FBI 14344 1
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |